Hillcrest Labs' Freespace Always-On Sensing Software Available on Cadence Tensilica DSP
Interop Technologies Selects Taqua for VoWiFi and VoLTE
Actavis Receives Final Approval for Generic Version of Subutex®
Vanda Pharmaceuticals Reports Fourth Quarter 2014 and Full Year 2014 Financial Results
IMTC Announces 20th Annual SuperOp! Multimedia Products and Services Interoperability Testing Event
Actavis to Divest Pharmatech to TPG
IMS Health is on the right track for growth.
Despite the Fed taper, a U.S. economy struggling to shake off the winter blues, and a slowing China, stocks continued their remarkable winning streak from April through June.
Regulatory issues that we believe have little impact on Novo Nordisk's long-run prospects have finally helped shares of the leading insulin maker go on sale.